Search Results

Directive 2010/45/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation

OJ L 207, 6.8.2010, p. 14–29 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
This document has been published in a special edition(s) ( HR)

OJ L 207, 6.8.2010, p. 14–29

Latest consolidated version:

06/08/2010

Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells

OJ L 102, 7.4.2004, p. 48–58 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) ( CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

OJ L 102, 7.4.2004, p. 48–58

Latest consolidated version:

07/08/2009

Decision of the EEA Joint Committee No 39/2021 of 5 February 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3]

OJ L, 2024/3, 11.1.2024, ELI: http://data.europa.eu/eli/dec/2024/3/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L, 2024/3, 11.1.2024, ELI: http://data.europa.eu/eli/dec/2024/3/oj

Case T-264/19: Judgment of the General Court of 5 October 2020 — nanoPET Pharma v EUIPO — Miltenyi Biotec (viscover) (EU trade mark — Invalidity proceedings — EU figurative mark viscover — Absence of bad faith — Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) No 2017/1001) — Article 53(2)(c) of Regulation No 207/2009 (now Article 60(2)(c) of Regulation 2017/1001))

OJ C 414, 30.11.2020, p. 35–35 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 414, 30.11.2020, p. 35–35

Case C-649/18: Judgment of the Court (Third Chamber) of 1 October 2020 (request for a preliminary ruling from the Cour d’appel de Paris — France) — A v Daniel B, UD, AFP, B, L (Reference for a preliminary ruling — Medicinal products for human use not subject to compulsory medical prescription — Online sales — Advertising for a pharmacy’s website — Limitations — Prohibition on discounts where the order exceeds certain amounts and the use of paid referencing — Obligation to require a patient to complete a health questionnaire prior to validation of his or her first order on a pharmacy’s website — Protection of public health — Directive 2000/31/EC — Electronic commerce — Article 2(a) — Information society service — Article 2(h) — Coordinated field — Article 3 — Country-of-origin principle — Derogations — Justification — Protection of public health — Protection of the dignity of the profession of pharmacist — Prevention of the abusive consumption of medicinal products)

OJ C 399, 23.11.2020, p. 8–8 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 399, 23.11.2020, p. 8–8

Case C-786/18: Judgment of the Court (Third Chamber) of 11 June 2020 (request for a preliminary ruling from the Bundesgerichtshof — Germany) — ratiopharm GmbH v Novartis Consumer Health GmbH (Reference for a preliminary ruling — Protection of public health — Internal market — Medicinal products for human use — Directive 2001/83/EC — Advertising — Article 96 — Distribution of free samples of medicinal products to persons qualified to prescribe them — Pharmacists excluded from the distribution of free samples of medicinal products — Inapplicability to distribution of free samples of non-prescription medicinal products — Consequences for the Member States)

OJ C 271, 17.8.2020, p. 8–8 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 271, 17.8.2020, p. 8–8

Commission Implementing Decision (EU) 2019/1396 of 10 September 2019 laying down the rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards the designation of expert panels in the field of medical devices (Text with EEA relevance.)

C/2019/6414

OJ L 234, 11.9.2019, p. 23–30 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 234, 11.9.2019, p. 23–30

Case C-387/18: Judgment of the Court (Fifth Chamber) of 3 July 2019 (request for a preliminary ruling from the Wojewódzki Sąd Administracyjny w Warszawie — Poland) — Delfarma sp. z o.o. v Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (Reference for a preliminary ruling — Articles 34 and 36 TFEU — Free movement of goods — Measure having equivalent effect to a quantitative restriction — Protection of health and life of humans — Parallel import of medicinal products — Reference medicinal products and generic medicinal products — Requirement that the imported medicinal product and that which has been granted a marketing authorisation in the Member State of importation are both reference medicinal products or are both generic medicinal products)

OJ C 305, 9.9.2019, p. 23–23 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 305, 9.9.2019, p. 23–23

Case T-264/19: Action brought on 18 April 2019 — nanoPET Pharma v EUIPO — Miltenyi Biotec (viscover)

OJ C 206, 17.6.2019, p. 94–95 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 206, 17.6.2019, p. 94–95

Case C-786/18: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 14 December 2018 — ratiopharm GmbH v Novartis Consumer Health GmbH

OJ C 112, 25.3.2019, p. 23–23 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 112, 25.3.2019, p. 23–23